September 8, 2003 |
|||||
FDA Official and Title | Date and Site | Other FDA Participants | Non-FDA Participants | Subject | |
---|---|---|---|---|---|
Jesse Goodman, M.D., Director, Center for Biologics Evaluation and Research | 8/25/03 Cambridge, MD | Mark Elengold and other staff | Conference Registrants | Facing the Challenges of a Changing Paradigm: GMP Update | |
Jesse Goodman, M.D., Director, Center for Biologics Evaluation and Research | 8/28/03 Bethesda, MD | CBER Office of Blood Research and Review Staff; Jay Epstein, M.D. | American Association of Blood Banks (AABB) Staff | Issues related to West Nile Virus (WNV) | |
Amit K. Sachdev, Associate Commissioner for Legislation | 9/3/03 Washington, DC | None | Sarah Amundson, Doris Day Animal Foundation | MUMS Legislation |
Public Calendar Archives | FDA Home Page | Search | A-Z Index | Site Map | Contact FDA